Maternal serum screening risk for Down syndrome is considered positive if a triple-marker-derived risk exceeds the age-specific risk: Use of this definition for women aged 35 and over

1993 ◽  
Vol 13 (2) ◽  
pp. 152-153 ◽  
Author(s):  
Joan Fitzgerald ◽  
Karen Streets ◽  
Jean Priest
Keyword(s):  
Down Syndrome ◽  
Maternal Serum ◽  
Maternal Serum Screening ◽  
Specific Risk ◽  
Serum Screening

Second-trimester Down syndrome maternal serum screening in twin pregnancies: impact of chorionicity

2003 ◽  
Vol 23 (4) ◽  
pp. 331-335 ◽  
Author(s):  
Fran�oise Muller ◽  
Sophie Dreux ◽  
Henry Dupoizat ◽  
Serge Uzan ◽  
Marie-Fran�oise Dubin ◽  
...  
Keyword(s):  
Down Syndrome ◽  
Maternal Serum ◽  
Second Trimester ◽  
Maternal Serum Screening ◽  
Serum Screening ◽  
Twin Pregnancies

scholarly journals How important is consent in maternal serum screening for Down syndrome in France? Information and consent evaluation in maternal serum screening for Down syndrome: a French study

2007 ◽  
Vol 27 (3) ◽  
pp. 197-205 ◽  
Author(s):  
Romain Favre ◽  
Nathalie Duchange ◽  
Christophe Vayssière ◽  
Monique Kohler ◽  
Nicole Bouffard ◽  
...  
Keyword(s):  
Down Syndrome ◽  
Maternal Serum ◽  
Maternal Serum Screening ◽  
French Study ◽  
Serum Screening

Screening for Down syndrome in the first trimester

1995 ◽  
Vol 7 (6) ◽  
pp. 1413 ◽  
Author(s):  
KJ Powell ◽  
JG Grudzinskas
Keyword(s):  
Down Syndrome ◽  
First Trimester ◽  
Maternal Blood ◽  
Maternal Serum ◽  
Published Data ◽  
Maternal Serum Screening ◽  
Ultrasound Findings ◽  
Serum Screening ◽  
Associated Proteins ◽  
Trimester Screening

Second-trimester maternal serum screening for Down syndrome is now well established, and permits detection of up to 70% of cases. The disadvantage of this sort of screening is that the timing of maternal blood sampling is relatively late (after 15 weeks). There is an accumulating body of evidence to suggest that in the first trimester concentrations of a number of pregnancy-associated proteins and hormones differ in chromosomally normal and abnormal pregnancies. A first-trimester maternal serum screening test for Down syndrome may therefore be possible. In addition, new methods of screening have recently been described based on ultrasound findings at 11 to 13 weeks of gestation. This review article presents a discussion of published data on the feasibility of first-trimester screening for Down syndrome.

ARE DOWN SYNDROME FETUSES DETECTED THROUGH MATERNAL SERUM SCREENING SIMILAR TO THOSE REMAINING UNDETECTED?

1996 ◽  
Vol 16 (5) ◽  
pp. 437-442 ◽  
Author(s):  
G. C. M. L. CHRISTIAENS ◽  
A. M. HAGENAARS ◽  
C. AKKERMAN ◽  
H. F DE FRANCE
Keyword(s):  
Down Syndrome ◽  
Maternal Serum ◽  
Maternal Serum Screening ◽  
Serum Screening

Karyotypes found in the population declared at increased risk of Down syndrome following maternal serum screening

2001 ◽  
Vol 21 (7) ◽  
pp. 553-557 ◽  
Author(s):  
Richard G. Ryall ◽  
David Callen ◽  
Robert Cocciolone ◽  
Amra Duvnjak ◽  
Renata Esca ◽  
...  
Keyword(s):  
Down Syndrome ◽  
Maternal Serum ◽  
Maternal Serum Screening ◽  
Increased Risk ◽  
Serum Screening

Second-trimester maternal serum screening for fetal Down syndrome: As a screening test for hemoglobin Bart's disease: A prospective population-based study

2018 ◽  
Vol 38 (9) ◽  
pp. 700-705 ◽  
Author(s):  
Chanane Wanapirak ◽  
Wirawit Piyamomgkol ◽  
Supatra Sirichotiyakul ◽  
Fuanglada Tongprasert ◽  
Kasemsri Srisupundit ◽  
...  
Keyword(s):  
Down Syndrome ◽  
Screening Test ◽  
Population Based ◽  
Maternal Serum ◽  
Second Trimester ◽  
Maternal Serum Screening ◽  
Population Based Study ◽  
Serum Screening
Sign in / Sign up

Export Citation Format

Share Document